SPRC SciSparc Ltd: Rentabilitas operasi

SciSparc Ltd (SPRC) is implementing software robotics for clinical data analysis, which is reflected in the operating margin, currently positioned around -660.50. The business model relies on the full outsourcing of synthesis and testing to third-party organizations. High patent barriers and the cost of neurobiological trials limit the entry of new players into this sector.
SciSparc Ltd - rincian analitis lan metrik utama (SPRC)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi saham perusahaan:
- rincian nilai buku perusahaan:
- data utang lan likuiditas:
Utang marang Ekuitas SciSparc Ltd|SPRC - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal SciSparc Ltd.|SPRC - Gunggung utang perusahaan|Utang marang nilai buku Clearmind Medicine|SPRC - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan SciSparc|Indikator likuiditas cepet scisparc.com
- data bathi resik lan rasio valuasi:
SPRC - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep SciSparc Ltd|SPRC - Pangali rega marang bathi|Rega marang bathi mangsa ngarep scisparc.com|SPRC - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan SciSparc Ltd.|SPRC - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan SciSparc|SPRC - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan scisparc.com|SPRC - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep SciSparc Ltd
- indikator pendapatan dodolan lan penghasilan bisnis:
- statistik margin bisnis:
Analisis komprehensif perusahaan:Clearmind Medicine

Identifying fundamentally resilient assets requires analyzing a business's ability to generate earnings before interest and taxes. This metric measures the efficiency of operational processes, and in the case of SciSparc Ltd (SPRC), a strong patent portfolio in neuropharmacology minimizes pricing pressure, which is reflected in the stability of the operating EBIT margin.
Analisis pesaing SciSparc Ltd
Rentabilitas operasi Alkermes PLC|Margin operasi Avadel Pharma|Margin operasi ATAI|GHRS (GH Research PLC) - Tingkat bathi operasi|MindMed - Margin dodolan operasi|Margin operasi COMPASS Pathways PLC CMPS|LB Pharmaceuticals, Inc. - Margin operasi|Bright Minds Biosciences - Rasio bathi operasi|Vanda Pharmaceuticals Inc (VNDA) - Rentabilitas operasi|CYBN - Rentabilitas kegiatan operasi|Margin dodolan operasi ANRO|NRXP: Tingkat bathi operasi|Margin operasi CING|SILO (silopharma.com) - Tingkat bathi operasi|Rentabilitas operasi China Pharma Holdings CPHI|Tingkat bathi operasi CMND|PBM - Rentabilitas operasi|Tingkat bathi operasi SEEL (Seelos Therapeutics, Inc.)|Virpax (VRPX) - Rentabilitas operasi|Karuna Pharma (KRTX) - Margin operasi